Information  X 
Enter a valid email address
  Print      Mail a friend       More announcements

Monday 11 May, 2020

JP Morgan Sec LLC

Willis Towers Watson plc 8.3

RNS Number : 3546M
J.P. Morgan Securities LLC
08 May 2020
 

Ap19

 

FORM   8.3

 

IRISH TAKEOVER PANEL 

 

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

 

1.  KEY   INFORMATION

 

Nameofpersondealing (Note 1)

J.P. Morgan Securities LLC

Companydealtin

Willis Towers Watson plc

Classofrelevantsecuritytowhichthe dealingsbeingdisclosedrelate (Note 2)

US$0.000304635 ordinary shares

Date of dealing

7 May 2020

 

2.  INTERESTS AND SHORT POSITIONS

 

(a)  Interests   and   short   positions   (following   dealing)   in   the   class   of   relevant   security   dealt   in   (Note   3)


Long

Short


Number


(%)

Number


(%)

(1)Relevantsecurities

 827,878  0.64

1,188,388  0.92

(2) Derivatives (other than options)

 560,301  0.44

769,258  0.60

(3)Optionsandagreementstopurchase/sell



Total

 1,388,179  1.08

1,957,646  1.52

 

 

Ap20

 

1.  DEALINGS  (Note   4)

(a)  Purchases and sales

 

 

Purchase/sale

 

Numberofrelevantsecurities

 

Priceperunit (Note 5)

USD

Purchase

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Sale

37

100

200

487

1

1,100

1,363

151

50

10

590

600

201

1,497

23

390

17,766

13

 

1

2

1

20

1

4

1,100

1,363

1

7

1

1

4

2

19

10

21

1

6

16

2

1,397

1,497

4

1

100

3

16

7

4,815

190.6800

 190.7200

 191.3800

 191.4376

 191.4400

 192.0822

 192.1894

 192.4315

 192.4500

 192.4700

 192.4826

 192.5700

 192.6205

 192.6963

 192.7300

 193.1276

 193.1500

 193.2950

 

 190.6600

 191.0050

 191.3600

 191.5260

 191.6000

 191.9375

 192.0822

 192.1894

 192.2400

 192.3086

 192.3750

 192.4300

 192.4400

 192.4700

 192.5032

 192.6090

 192.6171

 192.6300

 192.6367

 192.6525

 192.6750

 192.6935

 192.6963

 192.7025

 192.8100

 192.8400

 192.9167

 192.9369

 192.9486

 193.1500

(b)  Derivatives transactions (other than options transactions)

 

Productname,

e.g. CFD

Natureoftransaction

(Note 6)

Numberofrelevantsecurities

(Note 7)

Priceperunit   (USD) (Note 5)

Equity Swap

Long

 

 

Short

1,497

155

 

1,100

1,363

10,000

192.6963

193.1500

 

192.0822

192.1894

193.1500

 

(c)  Options transactions in respect of existing relevant securities

 

 

(i)  Writing, selling, purchasing or varying

 

Productname,

e.g. call option

Writing, selling,purchasing,varyingetc.

Numberofsecurities towhichtheoptionrelates (Note 7)

Exercise price

Type, e.g.American,Europeanetc.

Expiry date

Optionmoney paid/receivedperunit (Note 5)








 

(ii)  Exercising

 

Productname,

e.g. call option

Numberofsecurities

Exercisepriceper unit (Note 5)




 

(d)  Other dealings (including transactions in respect of new securities) (Note 4)

 

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)




Ap21

 

2.  OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

 

 

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

 

 

 

 

 

 

 

 

 

 

Is a Supplemental Form 8 attached?  (Note   9)    NO

 

Dateofdisclosure

8 May 2020

Contact name

Alwyn Basch

Telephone number

0207 742 7407

If aconnectedEFM,nameofofferee/offerorwithwhichconnected

N/A

If aconnectedEFM,statenatureofconnection (Note 10)

N/A

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
ISEFVLFBBELXBBV

a d v e r t i s e m e n t